In the BioHarmony Drug Report Database

"Preview" Icon

Dasabuvir

Viekira Pak, Exviera (dasabuvir) is a small molecule pharmaceutical. Dasabuvir was first approved as Viekira Pak on 2014-12-19. It is used to treat chronic hepatitis c and hepatitis c in the USA. It has been approved in Europe to treat chronic hepatitis c. Viekira pak’s patents are valid until 2033-10-18 (FDA).

 

Trade Name

 

Exviera
 

Common Name

 

dasabuvir
 

ChEMBL ID

 

CHEMBL3137312
 

Indication

 

chronic hepatitis c, hepatitis c
 

Drug Class

 

Antivirals: RNA polymerase (NS5B) inhibitor

Image (chem structure or protein)

Dasabuvir structure rendering